Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1976 Sep 1;144(3):768-75.
doi: 10.1084/jem.144.3.768.

Fc receptor-mediated inhibition of murine B-lymphocyte activation

Fc receptor-mediated inhibition of murine B-lymphocyte activation

J L Ryan et al. J Exp Med. .

Abstract

Immobilized antigen-antibody complexes are able to inhibit the mitogenic response of murine spleen cells to the B-cell mitogen 8-bromo-3',5'-cyclic guanosine monophosphoric acid. This this inhibition is dependent on intact Fc fragments in the immobilized complexes. Soluble complexes do not mediate this inhibition. When lipopolysaccharide (lps) activation of B cells was studied, it was found that the mitogenic response was inhibited at all times tested between 2 and 7 days of culture. Also, the LPS-induced mitogenesis of nude spleen cells was inhibited by immobilized complexes, indicating that suppressor T cells probably play no significant role in the inhibition. Immobilized complexes inhibit polyclonal antibody responses in a serum-free system and in the presence of normal mouse serum, but are unable to inhibit in the presence of fetal calf serum (FCS). If nu/nu spleen cells are used, however, the FCS does not block the ability of the complexes to inhibit the polyclonal response. It is suggested that that antigen-antibody complexes under appropriate conditions may bind to B lymphocytes via their Fc receptors and trigger a central "off" signal which blocks proliferation and consequently antibody production.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Exp Med. 1975 Nov 1;142(5):1041-51 - PubMed
    1. J Exp Med. 1975 Mar 1;141(3):647-63 - PubMed
    1. J Immunol. 1975 Sep;115(3):741-4 - PubMed
    1. J Exp Med. 1975 Oct 1;142(4):814-26 - PubMed
    1. J Exp Med. 1975 Jan 1;141(1):97-111 - PubMed